- Home
- APLT vs TWIN Comparison
APLT vs TWIN Comparison
Compare APLT & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- TWIN
- Stock Information
- Founded
- APLT 2016
- TWIN 1918
- Country
- APLT United States
- TWIN United States
- Employees
- APLT N/A
- TWIN N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- TWIN Industrial Machinery/Components
- Sector
- APLT Health Care
- TWIN Industrials
- Exchange
- APLT Nasdaq
- TWIN Nasdaq
- Market Cap
- APLT 128.0M
- TWIN 152.3M
- IPO Year
- APLT 2019
- TWIN N/A
- Fundamental
- Price
- APLT $0.65
- TWIN $11.22
- Analyst Decision
- APLT Buy
- TWIN
- Analyst Count
- APLT 7
- TWIN 0
- Target Price
- APLT $6.10
- TWIN N/A
- AVG Volume (30 Days)
- APLT 7.5M
- TWIN 24.4K
- Earning Date
- APLT 03-05-2025
- TWIN 02-05-2025
- Dividend Yield
- APLT N/A
- TWIN 1.43%
- EPS Growth
- APLT N/A
- TWIN N/A
- EPS
- APLT N/A
- TWIN 0.68
- Revenue
- APLT N/A
- TWIN $304,470,000.00
- Revenue This Year
- APLT N/A
- TWIN N/A
- Revenue Next Year
- APLT $2,622.90
- TWIN N/A
- P/E Ratio
- APLT N/A
- TWIN $16.60
- Revenue Growth
- APLT N/A
- TWIN 6.98
- 52 Week Low
- APLT $0.60
- TWIN $10.22
- 52 Week High
- APLT $10.62
- TWIN $18.00
- Technical
- Relative Strength Index (RSI)
- APLT 20.60
- TWIN 45.75
- Support Level
- APLT $0.60
- TWIN $10.22
- Resistance Level
- APLT $0.74
- TWIN $11.46
- Average True Range (ATR)
- APLT 0.09
- TWIN 0.44
- MACD
- APLT 0.21
- TWIN -0.01
- Stochastic Oscillator
- APLT 13.53
- TWIN 54.05
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.